SUMMARY Two children aged 1 and 20 months developed alveolar hypoventilation syndrome. They suffered severe apnoeic episodes and periodically required assisted ventilation. Their ventilatory response to carbon dioxide was lower than that of normal children and the transcutaneous oxygen tension during sleep was well below the normal range. Treatment with medroxyprogesterone acetate resulted in an improved response to carbon dioxide, and assisted ventilation was no longer needed. Oxygen and carbon dioxide tensions improved but were still slightly abnormal during sleep. There were no clinical side effects of treatment but one infant had slight pituitary suppression.
Congenital failure of automatic control of ventilation is a rare but well known disorder in childhood.' Diminished responsiveness to co2 may be found in these infants, although neither (Fig. 1) . Transcutaneous Pco2 correlated well with the end alveolar Pco2 (r=0*96). When left without ventilatory support TcPo2 rapidly decreased to below 4 kPa. When hypoxia was relieved by 02 administration a further increase in Pco2 was observed. Oral theophylline (6 mg/kg) produced no change in blood gases. Naloxone (0-2 mg/kg) caused a reduction in end tidal Pco2 from 8x3 to 5 6 kPa and increased the TcPo2 from 3-1 to 7-O kPa, but the effect disappeared within minutes. After doxapram injection (1-25 mg/kg), Pco2 decreased from 8-3 to 5-9 kPa and Po2 increased from 3-1 to 4-3 kPa: this response lasted for about three hours.
Oral mredroxyprogesterone acetate produced a significant reduction in the end tidal Pco2 (Figs. 1  and 2(b) ) and an increase in TcPo2 (Fig. 2(a) (Fig. 4(b) (Fig.5(b) ). The co2 response curve shifted to the left and the slope became slightly rtificially ventilated before the test.
steeper (Fig. 4(a) ). Arousal occurred at Pco2 values greater than 7 kPa. Minute ventilation during sleep was virtually unchanged at 100 ml/min/kg.
The transcutaneous Po2 was still slightly below normal values (Fig. 5(a) Occasionally, constant positive airways pressure" has been reported to improve respiration in adults, but had no effect in this case study. Doxapram stimulated respiration, but was not used continuously because of the severe side effects associated with its use. Diaphragm pacing by electrical stimulation of the phrenic nerve has been tried in a few infants with central hypoventilation syndrome, but the long term prognosis has not been very promising and phrenic nerve pacing is not recommended before the age of 10 years.6 19 Medroxyprogesterone has been used occasionally, with some beneficial effects, in cases of central hypoventilation syndrome.9 Neither the ventilatory effects nor the possible endocrinological side effects are well documented. In our patients an appreciable improvement was obtained both in respect of end tidal Pco2 and TcPo2 values and the general condition of the patients during the treatment.
When drug treatment was interrupted the condition of the patient deteriorated. Medroxyprogesterone treatment improved ventilation in respect of Pco2 and Po2 but these values did not become normal. The general condition of both patients, however, was improved to such an extent that they were no longer dependent on assisted ventilation during the night. The tracheostoma in the first patient could be permanently closed, but this has not yet been possible in the second.
Based on ventilatory studies in the cat, Tok and Loeschcke20 suggested that the effect of progesterone on breathing is mediated via muscarinic receptors in structures in a superficial layer on the ventral surface of the medulla oblongata, possibly sensing (HW). Skatrud et a18 showed a stimulatory effect of medroxyprogesterone in normal boys, but although treatment did not alter the slope of the ventilatory co2 response curve, it had a threshold-lowering additative effect which is in agreement with our findings. This indicates that medroxyprogesterone probably has no effect where there is complete absence of a ventilatory co2 response (Fleming, personal communication) but can effectively strengthen reduced co2 responsiveness as in our two patients.
The suppression of pituitary gonadotrophins and adrenocorticotrophic hormone noted during treatment are not considered to be major side effects at this age. The glucocorticoid effects, however, indicate that in situations of physical stress, additional cortisol should be given to account for the moderate suppression of the pituitary-adrenal axis.
